CN Patent

CN112142730A — 杂芳基并四氢吡啶类化合物的固体形式及其制备方法

Assigned to Sichuan Kelun Biotech Biopharmaceutical Co Ltd · Expires 2020-12-29 · 5y expired

What this patent protects

本申请公开了一种式(I)的杂芳基并四氢吡啶类化合物的固体形式及其制备方法，所述固体形式包括晶体A、晶体B、晶体C和无定形形式，其中所述晶体B具有良好的物理化学稳定性。

USPTO Abstract

本申请公开了一种式(I)的杂芳基并四氢吡啶类化合物的固体形式及其制备方法，所述固体形式包括晶体A、晶体B、晶体C和无定形形式，其中所述晶体B具有良好的物理化学稳定性。

Drugs covered by this patent

Patent Metadata

Patent number
CN112142730A
Jurisdiction
CN
Classification
—
Expires
2020-12-29
Drug substance claim
No
Drug product claim
No
Assignee
Sichuan Kelun Biotech Biopharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.